Clinical trial
A Non-interventional Study of Postoperative or Post-Radiation trEatment Habits in Locally adVanced Prostate Cancer patiENTs (High Risk)- PREVENT
NCT02155998 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Study of Postoperative or Post-Radiation trEatment Habits in Locally adVanced Prostate Cancer patiENTs (High Risk)- PREVENT
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 16, 2014
- Completion date
- December 14, 2016
- Enrollment
- 200 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative or postradiation adjuvant androgen deprivation therapy in locally advanced prostate cancer (high and very high risk) patients